Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients Whose Disease is Not Adequately Controlled With Topical Prescription Therapies or When Those Therapies Are Not Medically Advisable

NCT03849716 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT03849716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03849716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients Whose Disease is Not Adequately Controlled With Topical Prescription Therapies or When Those Therapies Are Not Medically Advisable
Lead sponsor
Sanofi
Phase
Observational
Overall status
Completed
Start date
April 5, 2019
Completion date
April 20, 2026
Enrollment
266 (actual)
Sites
48

Conditions

As the registry lists them; a condition with its own page is linked.

dermatitis atopic